semaglutide histamine Antihistamines in MCAS aren't a cure. They don't “fix” mast cells — they Use of new diet drugs

The exact mechanisms that are preventing GLP-1 drugs from having an effect still need to be investigated

TIR-HG prevented the HG-induced changes in protein levels of pAkt, MAP2, GAP43 (Fig

Patients with type 2 diabetes who want an oral semaglutide option currently have Rybelsus (7 mg or 14 mg), which is approved for glycemic management though at lower doses and with a different primary indication

References: Heyder NA, Kleinau G, Speck D, Schmidt A, Paisdzior S, Szczepek M, Bauer B, Koch A, Gallandi M, Kwiatkowski D, Brger J, Mielke T, Beck-Sickinger AG, Hildebrand PW, Spahn CMT, Hilger D, Schacherl M, Biebermann H, Hilal T, Khnen P, Kobilka BK, Scheerer P

A few key insights: Patients are actively self-directing care, often sharing detailed dosing protocols and recovery strategies Anecdotal success stories are common, but highly variable and often used to justify self-experimentation There is a clear trend toward DIY medicine and peer-to-peer decision making, sometimes replacing physician guidance Skepticism toward traditional healthcare and regulatory systems is a major driver of adoption Safety concernsincluding side effects, unknown dosing, and product purityare frequently discussed The bigger picture: There is a rapidly widening gap between patient-driven use of peptides and the lack of high-quality clinical evidence guiding their safety and efficacy

The direct-to-consumer cash prices of Novo Nordisk's oral drug are likely "significantly less" than what employers and middlemen called pharmacy benefit managers would pay to cover the drugs, said John Crable, senior vice president of Corporate Synergies, an insurance and employee benefits brokerage and consultancy